Ben Mullish
@bhmullish
MRC Clinician Scientist Fellow and Honorary Consultant in Hepatology and Gastroenterology, based at Imperial College London. Tweets in a personal capacity.
Great to see this work from Shiv Radhakrishnan and colleagues out in #GutMicrobes - using network analysis to explore #microbiome #metabolome interactions in an #IBD inception cohort: doi.org/10.1080/194909… @IHepatology @ImperialMDR @KorcsmarosLab
A great privilege to work with @JulieAKMcDonald lab @CBRB_Imperial on this new paper, now out in @NatureComms - how #antibiotic-related changes in gut #nutrients and #metabolites promote #VRE colonisation: doi.org/10.1038/s41467… @IHepatology @ImperialMDR @BRCinfection
Unravelling the gut microbiome with @bhmullish and @gianluca1aniro We talk #microbiome #FMT #microbiomemanupulation #biotherapeutics #microbiomeisnotdead And much much more! Check it out here podcasts.apple.com/gb/podcast/two…
How common is #MASLD in those with chronic #HepB, and how does this impact #fibrosis and outcome? Results from a large European cohort - led by @penny_manousou, @ForlanoRoberta and colleagues - out now in @AGA_CGH: cghjournal.org/article/S1542-… @ImperialMDR
🚨 New review alert! 🚨. Fantastic work @bhmullish and team on the complex area of MASLD 👏. What you will learn if you have a read 🧑🎓. ✅ A two-tier system to highlight those in primary care who need specialist input ✅ Non-invasive tests used for the diagnosis and management…
Another great month for PROMISE! Special thank you to Notts, Glasgow, SMH and KCH for randomising a total of 7 new patients in June so far! 👏@DebbieShawcros1 @NHSNotts @NHSGGC @dr_rach_swann @vtkronsten @DrVishalCPatel @AneZamalloa @bhmullish @MarkThursz
Very pleased to see this out in @FrontGastro_BMJ, our update on diagnosis and staging in #MASLD: fg.bmj.com/content/early/… @penny_manousou @IHepatology @ImperialMDR @ForlanoRoberta
Great to see this out in #JCEM @TheEndoSociety - the relationships between #MASLD, extrahepatic multimorbidity and all cause mortality in @uk_biobank: doi.org/10.1210/clinem… @ImperialMDR @IHepatology
Glad that we are up and running in the @PROMISE_Trial at @IHepatology @ImperialMDR, and looking forward to exploring the impact of #FMT in #cirrhosis
Big congrats to the @ImperialNHS team for recruiting you first PROMISE participant! 👏👏@bhmullish @MarkThursz #NIHRResearch #ClinicalTrials #FMT #ICL #StMarysHospital
✅Daily supplementation for 8 weeks with #Lab4 #probiotic led to improvements in female #IBS patients 🔥 @bhmullish & colleagues👏 ⬇️ IBS-SSS, anxiety & depression scores ▶️improved #bowel habits 👉onlinelibrary.wiley.com/doi/full/10.11… @ANMSociety @esnm_eu
A great first day at the @BritSocGastro #GutMicrobiome event in Edinburgh, covering everything from early life @hall_lab, to #liver @DebbieShawcros1, to #cancer @bowelsurgeon, and culminating in a tour de force on #IBD and the #microbiome in clinical practice from @h_sokol

📢 Five weeks to go until the @BritSocGastro meeting in Edinburgh "Transforming Medicine through the Gut/Microbiota Interface: Towards Microbial Therapeutics for Human Diseases". Outstanding list of speakers on clinically and translationally relevant topics. Come and join us…
Myself and so many people at @IHepatology @ImperialMDR @ImperialNHS will miss @ForlanoRoberta so much, a dear friend and wonderful colleague - to you and your family, arrivederci e buona fortuna! 🇮🇹 🇬🇧
I first arrived in the UK as a trainee in 2016, for what I thought it would have been a short experience abroad. 9 years later, I leave the country as an experienced senior researcher and consultant hepatologist! It's been a hell of a journey but I have enjoyed all of it, truly!
Pleased that #FARGO - a randomised, multicentre, placebo-controlled phase IIa trial of #FMT to treat #PSC - is running and recruiting. Have a look at the protocol paper out now in @BMJ_Open: doi.org/10.1136/bmjope… @lifearc1 @PSCSupportUK @CholestasisDoc @ImperialMDR
A new MDR supported trial to find out if ‘faecal microbiota transplant’ (FMT) therapy can slow PSC, a rare disease where the body attacks its own liver, has received funding from @lifearc1 and @PSCSupportUK. 👇 imperial.ac.uk/news/233874/ne… @bhmullish
Now out - protocol paper for the #MAST trial, exploring #IMT #FMT to #prehabilitate the #GutMicrobiome in #BloodCancer patients receiving #HCT, now in @BMJ_Open: doi.org/10.1136/bmjope… . Grateful to @The_MRC #DPFS for funding and @EnteroBiotix as project partners @ImperialMDR
